Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
A randomized, controlled, split‐face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea — Danfeng Wei (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
A randomized, controlled, split‐face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea
Shared by
Michael R Hamblin
A randomized, controlled, split‐face study of topical timolol maleate 0.5% eye drops for the treatment of erythematotelangiectatic rosacea
Article
2021
en
Authors
DW
Danfeng Wei
Michael R Hamblin
XW
Xiang Wen
Abstract
1 min read
In this small study, the application of topical timolol maleate was safe and effective for the treatment of ETR.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2020
A randomized split‐face, investigator‐blinded study of a picosecond Alexandrite laser for post‐inflammatory erythema and acne scars
Xiang Wen
,
Yong Li
,
Michael R Hamblin
,
Xian Jiang
Article
2000
Topical sucralfate in the management of peristomal skin disease: an open study
Calum C. Lyon
,
M Stapleton
,
Amanda Smith
,
Christopher Em Griffiths
,
M. H. Beck
Article
2020
Comparison of Fractional Micro‐Plasma Radiofrequency and Fractional Microneedle Radiofrequency for the Treatment of Atrophic Acne Scars: A Pilot Randomized Split‐Face Clinical Study in China
Ting Lan
,
Li Tang
,
Aiai Xia
,
Michael R Hamblin
,
Dan Jian
,
Rui Yin
Article
1997
The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study
Sauder Dn
,
Robert F. Miller
,
David Gratton
,
William Danby
,
Christopher Em Griffiths
,
Sb Phillips
Article
1999
Intermittent short courses of cyclosporin (Neoral®) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study
Ho
,
Christopher Em Griffiths
,
Albrecht
,
Vanaclocha
,
León-Dorantes
,
Atakan
,
Reitamo
,
Ohannesson
,
Mørk
,
Clarke
,
Pfister
,
C. Paul
Discussion(0)
No comments yet. Be the first to comment.